Cedar Hill Associates »

SPDR S&P Biotech shares owned by Cedar Hill Associates

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Cedar Hill Associates from 13F filings

Historical chart of Cedar Hill Associates investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Cedar Hill Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Cedar Hill Associates

Quarter filed Position value Share count Share price at filing
2018-12-31 $419k 5.8k 71.69

More positions owned by Cedar Hill Associates

Vaneck Vec Invt Grade Fltg Rate Etf etf/closed end fund (FLTR)
iShares S&P 500 Index (IVV)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Vanguard Short-Term Bond ETF (BSV)
iShares S&P MidCap 400 Index (IJH)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Tortoise Energy Infrastructure
iShares S&P SmallCap 600 Index (IJR)
Nuveen Barclays Shrt Term Muni bdfund (SHM)
Vanguard Emerging Markets ETF (VWO)
Brookfield Asset Management
Apple (AAPL)
Ishares Tr core msci intl (IDEV)
IAC/InterActive
Thermo Fisher Scientific (TMO)

View all positions for Cedar Hill Associates

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech